Related Experiment Video
Updated: Sep 15, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists
Insights
Postoperative hyperaldosteronism in children undergoing heart surgery leads to body potassium loss. Aldosterone antagonists did not alter this effect or reduce potassium depletion.
Area of Science:
- Pediatric Surgery
- Endocrinology
- Cardiovascular Surgery
Background:
- Postoperative hyperaldosteronism is a potential complication following cardiac surgery in children.
- Fluid and electrolyte imbalances, particularly potassium loss, can occur in the postoperative period.
Purpose of the Study:
- To investigate the effects of postoperative hyperaldosteronism on fluid and electrolyte metabolism in pediatric cardiac surgery patients.
- To evaluate the efficacy of aldosterone antagonists in mitigating these effects.
Main Methods:
- Studied serum and red cell electrolytes (sodium, potassium) and hematocrit in children post-heart surgery.
- Compared open versus closed heart surgery outcomes.
- Administered aldosterone antagonists preoperatively to a subset of open heart surgery patients.
Main Results:
- Transient hyponatremia and persistent hypokalemia were observed, indicating body potassium loss.
- No significant differences in electrolyte changes between open and closed heart surgery groups.
- Aldosterone antagonists did not alter the course or extent of hyperaldosteronism or prevent potassium loss.
Conclusions:
- Postoperative hyperaldosteronism in pediatric cardiac surgery patients is associated with significant potassium loss.
- The aldosterone antagonists tested, at the dosages used, were ineffective in altering the course of hyperaldosteronism or preventing potassium loss.
Abstract:
The course of postoperative hyperaldosteronism and its effect on fluid and electrolyte metabolism were studied in children undergoing open and closed heart surgery. Serum sodium was transiently depressed and red cell sodium concentration remained unchanged. Serum and red cell potassium concentrations were low. Hematocrit did not change significantly during the postoperative period ruling out overhydration. Therefore, the electrolyte changes are interpreted to indicate body potassium loss. That hyperaldosteronism caused potassium loss is suggested by an inverse relationship between plasma aldosterone and red cell potassium concentration. No significant differences were observed between patients undergoing open and those undergoing closed heart surgery. An additional, alternately selected group of patients undergoing open heart surgery was treated with aldosterone antagonists beginning 48 hours before surgery. Treatment did not change the course or extent of hyperaldosteronism. Specifically, potassium loss was not diminished and there was no difference in urine volume postoperatively. We conclude that aldosterone antagonists in the dosage used had no effect on the course of postoperative hyperaldosteronism.
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Aortic Regurgitation III: Medical Management
Heart Failure VI: Adjunct Therapies
Kidney Transplant II: Surgical Procedure

